Dr. McGowan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-6224Fax+1 513-579-8832
Education & Training
- UMass Chan Medical SchoolResidency, Internal Medicine, 1987 - 1990
- University of Massachusetts Medical SchoolClass of 1987
Certifications & Licensure
- NH State Medical License 1992 - 2026
- VT State Medical License 2022 - 2024
- OH State Medical License 2011 - 2012
- MD State Medical License 1990 - 1993
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 150 citationsRandomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering TherapyMary P. McGowan, Jean-Claude Tardif, Richard Ceska, Lesley J. Burgess, Handrean Soran
Plos One. 2012-11-13 - 218 citationsApolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia Results of a Randomized, Double-Blind, Placebo-Controlled Trial to ...Evan A. Stein, Robert Dufour, Claude Gagné, Daniel Gaudet, Cara East
Circulation. 2012-11-06 - 102 citationsDiagnosis and Treatment of Heterozygous Familial HypercholesterolemiaMary P. McGowan, Seyed Hamed Hosseini Dehkordi, Patrick M. Moriarty, P. Barton Duell
Journal of the American Heart Association. 2019-12-17
Press Mentions
- Should Children Be Tested for Cholesterol?March 1st, 2020
- Esperion Therapeutics: What Are the Risks to ETC 1002’S Efficacy?June 3rd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: